Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- Acinetobacter 1
- Adolescent 10
- Adult 11
- Aerosols 1
- Aged 12
- Aged, 80 and over 6
- Age Distribution 1
- Age Factors 1
- Air Microbiology 1
- Ambulatory Care 2
- Animals 3
- Anti-Bacterial Agents 12
- Anti-Bacterial Agents/pharmacology 1
- Anti-Infective Agents 1
- Antibiotic stewardship 1
- Antibodies, Viral 1
- Antifungal Agents 1
- Article 8
- Athletes 1
- Bacteremia 1
- Bacteria 1
- Bacterial Infections 2
- Bacterial Proteins 3
- Bacterial Toxins 5
- Bacterial Typing Techniques 1
- Bacterial Vaccines 1
- beta-Lactamases 2
- Black or African American 1
- Carbapenems 3
- Catheter-Related Infections 2
- Cattle 3
- CDI 1
- Cephalosporin Resistance 2
- Child 7
- Child, Preschool 8
- Clostridioides difficile 5
- Clostridioides difficile infection 2
- Clostridium difficile 6
- Clostridium Infections 12
- Cohort Studies 3
- Community-Acquired Infections 5
- COVID-19 2
- COVID-19/Prevention & Control 1
- Cross-Sectional Studies 3
- Cross Infection 10
- Databases, Factual 2
- Diarrhea 3
- Disease Outbreaks 3
- Dispatch 4
- Drug Resistance, Bacterial 4
- Drug Resistance, Microbial 2
- Drug Resistance, Multiple, Bacterial 4
- Drug Utilization 2
- Electrophoresis, Gel, Pulsed-Field 2
- Enterobacteriaceae 4
- Enterobacteriaceae Infections 3
- Enterocolitis, Pseudomembranous 6
- Enterotoxins 2
- Feces 3
- Female 20
- Food Contamination 2
- Gastrointestinal Diseases 2
- Gastrointestinal Microbiome 2
- Health Personnel 2
- Hospitalization 6
- Hospitals 7
- Hospitals, Teaching 2
- Humans 39
- Incidence 6
- Infant 8
- Infant, Newborn 3
- Infection Control 5
- Inpatients 2
- Length of Stay 3
- Major Articles 3
- Male 19
- Methicillin-Resistant Staphylococcus aureus 2
- Microbial Sensitivity Tests 3
- Microbiota 3
- Middle Aged 15
- Multivariate Analysis 2
- outcomes 2
- Patient Discharge 2
- Polymerase Chain Reaction 2
- Population Surveillance 2
- Prevalence 3
- Research 9
- Retrospective Studies 7
- Ribotyping 3
- Risk Assessment 2
- Risk Factors 6
- SARS Virus 2
- Sars Virus 2
- Sepsis 2
- Severe Acute Respiratory Syndrome 6
- Staphylococcal Infections 3
- Time Factors 2
- Travel 2
- United States 6
- Young Adult 7
Personal Author
Corporate Author
- CDC COVID-19 Response Team 1
- CDC COVID-19 Response Team. 1
- Center for Infectious Disease Research & Policy 1
- Centers for Disease Control and Prevention (U.S.) 1
- Centers for Disease Control and Prevention (U.S.). Office for State, Tribal, Local and Territorial Support. 1
- Clostridium difficile Infection Surveillance Investigators, Centers for Disease Control and Prevention 1
- Duke Center for Antimicrobial Stewardship and Infection Prevention. 1
- Emerging Infections Program C. difficile Infection Working Group 2
- Emerging Infections Program C. difficile Surveillance Team 1
- Emerging Infections Program MRSA author group 1
- for the CDC Infection Prevention and Control Team and the CDC COVID-19 Surge Laboratory Group* 1
- IQVIA Real-World Solutions. 1
- National Center for Emerging and Zoonotic Diseases (U.S.)Division of Healthcare Quality Promotion. 1
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. 1
- National Football League. 1
- National Football League Players Association. 1
- National Healthcare Safety Network. 1
- NFL COVID-19 Advisory and Operational Team. 1
- on behalf of the SARS Investigation Team 1
- Project COVERED Emergency Department Network 1
Place as Subject
- Arizona 1
- Asia 1
- Canada 3
- Connecticut 1
- Maryland 1
- New York 1
- North Carolina 1
- Ontario, Canada 2
- Pennsylvania 1
- United States 18
Resource Type General
- Journal Article 65
- Presentation 1
- Report 1
- Webpage 1
Resource Type Specific
- Webinar 1
Keywords
- administrative data 1
- Adult 1
- agar dilution 2
- Aged 2
- Aged, 80 and over 1
- Animals 1
- Anti-Bacterial Agents 5
- anti-bacterial agents 1
- antibiotic resistance 3
- antibiotic stewardship 1
- antimicrobial resistance 1
- antimicrobial stewardship 1
- bacteria 1
- Bacterial Infections 1
- Bifidobacterium 1
- California 1
- Carrier State 2
- Catheter-Related Infections 1
- CDI 2
- CDI risk score 1
- Chlorination 1
- Clindamycin 1
- clinical laboratory techniques 1
- Clostridioides 2
- Clostridioides difficile 7
- Clostridium difficile 4
- Clostridium difficile Infection (CDI) 1
- Clostridium Infections 5
- colonization 1
- community-associated 1
- Cost-Benefit Analysis 1
- Cross Infection 6
- decolonization 1
- diagnostic test 1
- Dietary supplement 1
- Disinfection 1
- DNA, Bacterial 1
- Drug Prescriptions 1
- Drug Resistance, Multiple, Bacterial 2
- electronic health record (EHR) 1
- electronic medical record (EMR) 1
- Enterocolitis, Pseudomembranous 2
- epidemiologic trends 1
- Female 3
- Genomics 1
- Glucuronidase 1
- Growth Plate 1
- health-care associated infections 1
- healthcare-associated infection 2
- health outcomes 1
- Health Services Research 1
- Hexosaminidases 1
- hospital 1
- Hospitals 2
- Household water treatment 1
- human microbiome 1
- Humans 10
- Hydrogen Peroxide 1
- incidence 1
- Infection Control 3
- Infections 1
- Inpatients 1
- laboratory data 1
- Lactobacillus 1
- Male 3
- Markov Chains 1
- Medication Therapy Management 2
- metronidazole 2
- Metronidazole 1
- microbial 1
- Microbial Sensitivity Tests 1
- Middle Aged 1
- Moxifloxacin 1
- National Health Programs 1
- nucleic acid amplification techniques 1
- Pathogen reduction 1
- patient safety 1
- pediatric 1
- Practice Patterns, Physicians' 1
- predictive model 1
- Predictive Value of Tests 1
- prevalence 1
- Probiotic 1
- Research Design 1
- Retrospective Studies 1
- Ribotyping 1
- risk adjustment 1
- Risk Assessment 1
- Saccharomyces 1
- Safety Management 2
- Safe water storage 1
- sepsis 1
- septic shock 1
- surveillance 1
- Surveys and Questionnaires 1
- United States 3
- Urinary Tract Infections 1
- Value-Based Purchasing 1
- Vancomycin 2
- vancomycin 2
Select all docs (Max 200)
1 -
20 of 68 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- Acinetobacter (1)
- Adolescent (10)
- Adult (11)
- Aerosols (1)
- Aged (12)
- Aged, 80 and over (6)
- Age Distribution (1)
- Age Factors (1)
- Air Microbiology (1)
- Ambulatory Care (2)
- Animals (3)
- Anti-Bacterial Agents (12)
- Anti-Bacterial Agents/pharmacology (1)
- Anti-Infective Agents (1)
- Antibiotic stewardship (1)
- Antibodies, Viral (1)
- Antifungal Agents (1)
- Article (8)
- Athletes (1)
- Bacteremia (1)
- Bacteria (1)
- Bacterial Infections (2)
- Bacterial Proteins (3)
- Bacterial Toxins (5)
- Bacterial Typing Techniques (1)
- Bacterial Vaccines (1)
- beta-Lactamases (2)
- Black or African American (1)
- Carbapenems (3)
- Catheter-Related Infections (2)
- Cattle (3)
- CDI (1)
- Cephalosporin Resistance (2)
- Child (7)
- Child, Preschool (8)
- Clostridioides difficile (5)
- Clostridioides difficile infection (2)
- Clostridium difficile (6)
- Clostridium Infections (12)
- Cohort Studies (3)
- Community-Acquired Infections (5)
- COVID-19 (2)
- COVID-19/Prevention & Control (1)
- Cross-Sectional Studies (3)
- Cross Infection (10)
- Databases, Factual (2)
- Diarrhea (3)
- Disease Outbreaks (3)
- Dispatch (4)
- Drug Resistance, Bacterial (4)
- Drug Resistance, Microbial (2)
- Drug Resistance, Multiple, Bacterial (4)
- Drug Utilization (2)
- Electrophoresis, Gel, Pulsed-Field (2)
- Enterobacteriaceae (4)
- Enterobacteriaceae Infections (3)
- Enterocolitis, Pseudomembranous (6)
- Enterotoxins (2)
- Feces (3)
- Female (20)
- Food Contamination (2)
- Gastrointestinal Diseases (2)
- Gastrointestinal Microbiome (2)
- Health Personnel (2)
- Hospitalization (6)
- Hospitals (7)
- Hospitals, Teaching (2)
- Humans (39)
- Incidence (6)
- Infant (8)
- Infant, Newborn (3)
- Infection Control (5)
- Inpatients (2)
- Length of Stay (3)
- Major Articles (3)
- Male (19)
- Methicillin-Resistant Staphylococcus aureus (2)
- Microbial Sensitivity Tests (3)
- Microbiota (3)
- Middle Aged (15)
- Multivariate Analysis (2)
- outcomes (2)
- Patient Discharge (2)
- Polymerase Chain Reaction (2)
- Population Surveillance (2)
- Prevalence (3)
- Research (9)
- Retrospective Studies (7)
- Ribotyping (3)
- Risk Assessment (2)
- Risk Factors (6)
- SARS Virus (2)
- Sars Virus (2)
- Sepsis (2)
- Severe Acute Respiratory Syndrome (6)
- Staphylococcal Infections (3)
- Time Factors (2)
- Travel (2)
- United States (6)
- Young Adult (7)
- CDC COVID-19 Response Team (1)
- CDC COVID-19 Response Team. (1)
- Center for Infectious Disease Research & Policy (1)
- Centers for Disease Control and Prevention (U.S.) (1)
- Centers for Disease Control and Prevention (U.S.). Office for State, Tribal, Local and Territorial Support. (1)
- Clostridium difficile Infection Surveillance Investigators, Centers for Disease Control and Prevention (1)
- Duke Center for Antimicrobial Stewardship and Infection Prevention. (1)
- Emerging Infections Program C. difficile Infection Working Group (2)
- Emerging Infections Program C. difficile Surveillance Team (1)
- Emerging Infections Program MRSA author group (1)
- for the CDC Infection Prevention and Control Team and the CDC COVID-19 Surge Laboratory Group* (1)
- IQVIA Real-World Solutions. (1)
- National Center for Emerging and Zoonotic Diseases (U.S.)Division of Healthcare Quality Promotion. (1)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. (1)
- National Football League. (1)
- National Football League Players Association. (1)
- National Healthcare Safety Network. (1)
- NFL COVID-19 Advisory and Operational Team. (1)
- on behalf of the SARS Investigation Team (1)
- Project COVERED Emergency Department Network (1)
- administrative data (1)
- Adult (1)
- agar dilution (2)
- Aged (2)
- Aged, 80 and over (1)
- Animals (1)
- Anti-Bacterial Agents (5)
- anti-bacterial agents (1)
- antibiotic resistance (3)
- antibiotic stewardship (1)
- antimicrobial resistance (1)
- antimicrobial stewardship (1)
- bacteria (1)
- Bacterial Infections (1)
- Bifidobacterium (1)
- California (1)
- Carrier State (2)
- Catheter-Related Infections (1)
- CDI (2)
- CDI risk score (1)
- Chlorination (1)
- Clindamycin (1)
- clinical laboratory techniques (1)
- Clostridioides (2)
- Clostridioides difficile (7)
- Clostridium difficile (4)
- Clostridium difficile Infection (CDI) (1)
- Clostridium Infections (5)
- colonization (1)
- community-associated (1)
- Cost-Benefit Analysis (1)
- Cross Infection (6)
- decolonization (1)
- diagnostic test (1)
- Dietary supplement (1)
- Disinfection (1)
- DNA, Bacterial (1)
- Drug Prescriptions (1)
- Drug Resistance, Multiple, Bacterial (2)
- electronic health record (EHR) (1)
- electronic medical record (EMR) (1)
- Enterocolitis, Pseudomembranous (2)
- epidemiologic trends (1)
- Female (3)
- Genomics (1)
- Glucuronidase (1)
- Growth Plate (1)
- health-care associated infections (1)
- healthcare-associated infection (2)
- health outcomes (1)
- Health Services Research (1)
- Hexosaminidases (1)
- hospital (1)
- Hospitals (2)
- Household water treatment (1)
- human microbiome (1)
- Humans (10)
- Hydrogen Peroxide (1)
- incidence (1)
- Infection Control (3)
- Infections (1)
- Inpatients (1)
- laboratory data (1)
- Lactobacillus (1)
- Male (3)
- Markov Chains (1)
- Medication Therapy Management (2)
- metronidazole (2)
- Metronidazole (1)
- microbial (1)
- Microbial Sensitivity Tests (1)
- Middle Aged (1)
- Moxifloxacin (1)
- National Health Programs (1)
- nucleic acid amplification techniques (1)
- Pathogen reduction (1)
- patient safety (1)
- pediatric (1)
- Practice Patterns, Physicians' (1)
- predictive model (1)
- Predictive Value of Tests (1)
- prevalence (1)
- Probiotic (1)
- Research Design (1)
- Retrospective Studies (1)
- Ribotyping (1)
- risk adjustment (1)
- Risk Assessment (1)
- Saccharomyces (1)
- Safety Management (2)
- Safe water storage (1)
- sepsis (1)
- septic shock (1)
- surveillance (1)
- Surveys and Questionnaires (1)
- United States (3)
- Urinary Tract Infections (1)
- Value-Based Purchasing (1)
- Vancomycin (2)
- vancomycin (2)
- :Wise, Matthew E. ;Scott, R. DouglasApr 18 2013 | Infect Control Hosp Epidemiol. 34(6):547-554.:OBJECTIVERecent studies have demonstrated that central line–associated bloodstream infections (CLABSIs) are preventable through implementation of ev...
- :Scott, R. Douglas ;Slayton, Rachel B.Jan 22 2019 | Antimicrob Resist Infect Control. 8:BackgoundEconomic evaluations of interventions to prevent healthcare-associated infections in the United States rarely take the societal perspective a...
- :Sievert, Dawn ;Kirby, Amy4 09 2021 | Med (N Y). 2(4):365-369:Antibiotic resistance challenges public health on many fronts, and it is increasingly clear that it must be addressed in the environment to control em...
- :Songer, J. Glenn ;Trinh, Hien T.May 2009 | Emerg Infect Dis. 15(5):819-821.:To determine the presence of Clostridium difficile, we sampled cooked and uncooked meat products sold in Tucson, Arizona. Forty-two percent contained ...
- :Hunter, Jennifer C. ;Mu, YiJan 18 2016 | Open Forum Infect Dis. 2016; 3(1).:Background. Approximately 4 million Americans receive nursing home (NH) care annually. Nursing home residents commonly have risk factors for Clostr...
- :Dantes, Raymund ;Mu, YiAug 11 2015 | Open Forum Infect Dis. 2015; 2(3).:Background. Antibiotic use predisposes patients to Clostridium difficile infections (CDI), and approximately 32% of these infections are community-...
- :Lessa, Fernanda C. ;Mu, YiJul 28 2014 | Open Forum Infect Dis. 2014; 1(2).:Background Clostridium difficile infection (CDI) is no longer restricted to hospital settings, and population-based incidence measures are needed. U...
- :McKay, Susannah L. ;Tobolowsky, Farrell A.Apr 27 2021 | Ann Intern Med. 2021;:Background:To address high COVID-19 burden in U.S. nursing homes, rapid SARS-CoV-2 antigen tests have been widely distributed in those facilities. How...
- :Baggs, James ;Yousey-Hindes, KimberlyOctober 09 2015 | Vaccine. 33(46):6241-6249:BackgroundEfforts to develop a Clostridium difficile vaccine are underway; identification of patients at risk for C. difficile infection (CDI) is crit...
- :Kutty, Preeta K. ;Woods, Christopher W.Feb 2010 | Emerg Infect Dis. 16(2):198-204.:We determined estimated incidence of and risk factors for community-associated Clostridium difficile infection (CA-CDI) among patients treated at 6 No...
- :McCaig, Linda F. ;McDonald, L. CliffordNov 2006 | Emerg Infect Dis. 12(11):1715-1723.:To describe the number and treatment of skin and soft tissue infections likely caused by Staphylococcus aureus in the United States, we analyzed data ...
- :Tabak, Ying P. ;Johannes, Richard S.6 2015 | Infect Control Hosp Epidemiol. 36(6):695-701:ObjectiveTo predict the likelihood of hospital-onset Clostridium difficile infection (HO-CDI) based on patient clinical presentations at admissionDesi...
- :Arnold, Kathryn E. ;Baggs, James2013:The National Healthcare Safety Network (NHSN) is a public health surveillance system that the Centers for Disease Control and Prevention's (CDC) Divis...
- :Slayton, Rachel B. ;Scott, R. Douglas6 2015 | Infect Control Hosp Epidemiol. 36(6):681-687:OBJECTIVE.To determine the potential epidemiologic and economic value of the implementation of a multifaceted Clostridium difficile infection (CDI) co...
- :Guh, Alice Y. ;McDonald, L. Clifford6 01 2016 | JAMA Intern Med. 176(6):805-806
- :Jernigan, John A. ;McDonald, L. Clifford7 02 2020 | N Engl J Med. 383(1):94
- :McDonald, L. Clifford4-2015 | JAMA Intern Med. 175(4):633-634
- :Gerding, Dale N. ;File, Thomas M.1 2016 | Infect Dis Clin Pract (Baltim Md). 24(1):3-10:Early and accurate diagnosis is essential for optimal treatment of individuals with | infection (CDI) and for implementation of effective infection co...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.